» Articles » PMID: 35147580

Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya

Abstract

Objective: To present detailed analyses of long-term pre-exposure prophylaxis (PrEP) use and associated behaviors and perceptions among young Kenyan women.

Design: Prospective, observational cohort.

Methods: The Monitoring PrEP among Young Adult women Study involved 18 to 24-year-old women at high HIV risk initiating PrEP in Kisumu and Thika, Kenya. Visits for PrEP counseling and dispensing, HIV testing, and socio-behavioral data collection occurred at Month 1 and quarterly for 2 years. PrEP adherence was measured with pharmacy refill and real-time electronic monitoring, plus tenofovir diphosphate levels in 15% of participants. HIV risk behavior and perception were assessed by self-report in weekly short message service surveys from Months 6-24. Predictors of adherence were assessed with multivariable logistic regression analysis.

Results: Three hundred forty-eight women (median age 21, VOICE risk score 7) were followed for 617 person-years. Pharmacy refills steadily declined from 100% (Month 0-1) to 54% (Months 22-24). Average electronically monitored adherence similarly declined from 65% (Month 0-1) to 15% (Months 22-24). Electronically monitored adherence had moderately high concordance with tenofovir diphosphate levels (67%). High average adherence (5+ doses/week) was seen at 385/1898 (20%) participant-visits and associated with low baseline VOICE risk score, >1 current sexual partner, ≤1-hour travel time to clinic, and the Kisumu site. short message service-reported behavior and risk perception were not associated with adherence. Four women acquired HIV (incidence 0.7/100 person-years).

Conclusions: PrEP adherence was modest and declined over time. HIV risk was inconsistently associated with adherence; clinic access and site-level factors were also relevant. Relatively low HIV incidence suggests participants may have achieved protection through multiple strategies.

Citing Articles

Performance of indirect adherence measures for daily oral pre-exposure prophylaxis for HIV among adolescent men who have sex with men and transgender women in Brazil.

Zeballos D, Magno L, Soares F, Pinto Junior J, Amorim L, Greco D PLoS One. 2024; 19(12):e0310861.

PMID: 39739641 PMC: 11687640. DOI: 10.1371/journal.pone.0310861.


HIV Prevention Product Acceptability and Preference Among Women in Sub-Saharan Africa to Inform Novel Biomedical Options in Development: A Systematic Review.

Makoni W, Lorenzetti L, Mancuso N, Luecke E, Dinh N, Deshpande A AIDS Behav. 2024; 29(1):257-293.

PMID: 39422786 DOI: 10.1007/s10461-024-04529-2.


Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.

Lagat H, Pintye J, Harrington E, Houck S, Kwena Z, Lenn M Trials. 2024; 25(1):394.

PMID: 38890744 PMC: 11186170. DOI: 10.1186/s13063-024-08206-6.


Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial.

Ngure K, Browne E, Reddy K, Friedland B, van der Straten A, Palanee-Phillips T AIDS Behav. 2024; 28(9):2990-3000.

PMID: 38852114 PMC: 11572767. DOI: 10.1007/s10461-024-04382-3.


Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.

Ortblad K, Kuo A, Mogere P, Roche S, Kiptinness C, Wairimu N BMC Health Serv Res. 2024; 24(1):618.

PMID: 38730398 PMC: 11088131. DOI: 10.1186/s12913-024-10995-0.